Journals Books 2687-5527
Latest Issue Archive Future Issues About Us
Conference Proceedings

SETSCI - Volume 4 (6) (2019)
ISAS WINTER-2019 (ENS) - 4th International Symposium on Innovative Approaches in Engineering and Natural Sciences, Samsun, Turkey, Nov 22, 2019

Nanothermic Systems for Diagnosis and Treatment
Habibe Kutuk1, Tuğçe Karaduman2*
1Aksaray University, Aksaray, Turkey
2Aksaray University, Aksaray, Turkey
* Corresponding author:
Published Date: 2019-12-22   |   Page (s): 104-107   |    287     4

ABSTRACT Nanotechnology is the science of controlling materials at the atomic and molecular levels. With the use of nanomaterials for diagnostic and therapeutic purposes, the field of molecular nanotechnology has emerged, enabling nanoelectronic biosensors and individual medical applications. One of the most important areas in nanomedicine is drug targeting. In drug targeting, different targeted nanocarriers are used. The aim of drug targeting is the transport, absorption dispersion of the active substance to the selective site. Undesirable effects may occur if the dose rate falls below a sufficient amount or exceeds the toxic level. Today, drug carrier nanosystems are used, reducing the dose of active ingredient to eliminate these unexpected situations,prolonging dosing frequency, purify toxic effects,distributes the active ingredient to the desired area. These carriers are materials which that carry a variety of drugs or imaging agents. In this study, drug targeting and drug delivery systems will be discussed. For transporting drugs to specific or difficult-to-reach sites in the body, nanocarriers are targeted, with various agents or differences in structure. Drug delivery systems are divided into various classes as micelles, dendrimers, liposomes, nanoparticles and carbon nanotubes. There is a need to use an effective and suitable carrier system for effective entry into the cell.
KEYWORDS Nanotechnology, nanocarrier, drug targeting, the active ingredient.
REFERENCES [1] J. F. Mongillo, Nanotechnology, 101nd
[2] Davies, J. C., Managing the Effects of Nanotechnology: Woodrow Wilson International Center for Scholars. Science and Technology Innovation Program, Washington: july. 2006, pen 3.
[3] M. Kaplan,development of antıbıotıc loaded spacers for two stage total joınt replacement surgery: Department of Nanotechnology and Nanomedicine tez, Hacettepe university, Ankara, Turkey, January 2018.
[4] (2018) Teknoloji Projeleri website. [Online]. Available:
[5] D. Sousa, D. Ferreira, Joana L., and Rodrigues Lígia R., Rodrigues, ''Applications of Targeted Nano Drugs and Delivery Systems,'' ScienceDirect Nanoscience and Nanotechnology in Drug Delivery Micro and Nano Technologies., pp. 357-409, 2019.
[6] Zülfü Tüylek, ''Systems Used in the Field of Nanomedicine'' Archives Medical Review Journal., vol. 28(2), pp. 119-129, 2019.
[7] C. H. Mastrangelo, ''DNA analysis systems,'' on a chip, Adv. Sci. Technol., vol. 26, pp. 13-465, 1999.
[8] Zülfü Tüylek, ''Drug Delivery Nanosystems,'' Archives Medical Review Journal., pp. 184-192, 2019.
[9] Esfand R, Tomalia DA, Beezer AE, Mitchell JC, Hardy M and Orford C. ''Dendripore and dendrilock concepts new controlled delivery strategies,'' Polymer Preprints., vol 41, pp. 2-1324, 2000.
[10] Kocaefe Ç., ''Yaşam Bilimlerinde Nanoteknoloji Uygulamaları,'' Nanotıp H.Ü. Tıp Dergisi., vol 38(1), pp. 38:33-6, 2007.
[11] A. Erdoğan, A. Özkan, ''Nanotechnological Applications in Cancer Treatment and Tumor Imaging'' Archives Medical Review Journal., vol. 22(3), pp. 426-440, 2013.
[12] Y. Dağlıoğlu, H. Özkan Yılmaz and O. Yılmaz ''Nanoparticle Applications in Mammalian Tumor and Normal Cell Lines,'' Archives Medical Review Journal., vol. 27(2), pp. 136-174, 2018.
[13] Batrakova, E. V., Bronich, T. K., Vetro J.A. and Kabanov, A. V., ''Polymer Micelles as Drug Carriers.'' V. P. Torchilin içinde, Nanoparticulates as Drug Carriers London: Imperial Colloge Press., pp 57-93, 2006.
[14] Tyrrell ZL, Shen Y and Radosz M., ''Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers,'' Prog Polym Sci., vol. 35, pp. 43-1128, 2010.
[15] Groneberg DA, Giersig M, Welte T and Pison U., ''Nanoparticle-based diagnosis and therapy.'' Curr Drug Targets., pp. 7:643-8, 2006.
[16] Cheng Y, Xu Z, Ma M and Xu T., ''Dendrimers as drug carriers: applications in different routes of drug administration.'' J Pharm Sci., vol. 97, pp. 43-123, January 2008.
[17] Sahoo, S. K. and Labhasetwar, V., ''Nanotech approaches to drug delivery and imaging.'' Drug discovery today., vol. 8(24) pp. 1112-1120, 2003.
[18] Sarpa P, Tyagi P and Allen TM., ''Ligand-targeted liposomes for cancer treatment.'' Curr Drug Deliv., pp. 2:369-81, 2005.
[19] Zhao YZ, Dai DD, Lu CT, Chen LJ, Lin M, Shen XT et al., ''Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.'' Cancer Lett., vol. 330, pp. 74-83. 2012.
[20] Mukherjee S, Ray S and Thakur R., ''Solid lipid nanoparticles: a modern formulation approach in drug delivery system.'' Indian Journal of Pharmaceutical Sciences., pp. 71-349, 2009.
[21] Le Goff A, Holzinger M and Cosnier S., ''Enzymatic biosensors based on SWCNT-conducting polymer electrodes.,'' Analyst., pp. 136:1279-87, 2011.
[22] Beg S, Rizwan M, Sheikh AM, Hasnain MS, Anwer K and Kohli K., ''Advancement in carbon nanotubes: basics, biomedical applications and toxicity,'' J Pharm Pharmacol., vol. 63, pp. 63-141, 2011.
[23] Önyüksel H, Çomoğlu T., ''Nanotaşıyıcılarda Hedeflendirme. Zırh-Gürsoy A. Nanofarmasötikler ve Uygulamaları,'' Kontrollü Salım Sistemleri Derneği, İstanbul., pp. 16-211, 2014.
[24] Singh R, Lillard J.J.W., ''Nanoparticle Based Drug Delivers,'' Experimental and Molecular Pathology., pp. 9-215, 2009.

SET Technology - Turkey

eISSN  : 2687-5527    

E-mail :
+90 533 2245325

Tokat Technology Development Zone Gaziosmanpaşa University Taşlıçiftlik Campus, 60240 TOKAT-TURKEY
©2018 SET Technology